Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Median ADA titers peaked at week 40 (median of 1:160), plateaued up to week 52, and then declined to lower levels (Supplementary Fig
As of 2025, retatrutide has not received MHRA or EMA marketing authorisation in the UK and remains in Phase 3 clinical trials
Diabetes mellitus 2 (DM2) is a metabolic disease characterised by poor glycaemic control caused by increased insulin resistance
Researchers who prefer simplicity can use 10mg vials with 1mL reconstitution throughout the first 8-12 weeks (covering doses from 2mg through 8mg within a single draw), then switch to 20mg vials with 1mL reconstitution for the 8mg and 12mg maintenance phases
US$ 21.64
US$ 21.52
US$ 25.73
US$ 28.96
US$ 24.45
US$ 24.51
US$ 21.99
US$ 22.12
US$ 23.84
